References
- Rosati G. The prevalence of multiple sclerosis in the world: an update. Neurol Sci 2001;22:117–39
- Bencsik K, Rajda C, Füvesi J, et al. The prevalence of multiple sclerosis, distribution of clinical forms of the disease and functional status of patients in Csongrád County, Hungary. Eur Neurol 2001;46:206–9
- Lublin FD, Reingold Sc. Defining the clinical course of multiple sclerosis: results of an international survey. National Multiple Sclerosis Society (USA) Advisory Committee on clinical Trials of New Agents in Multiple Sclerosis. Neurology 1996;46:907–11
- Rejdak K, Jackson S, Giovanni G. Multiple sclerosis: a practical overview for clinicians. Br Med Bull 2010;95:79–104
- Confravreux C, Hutchinson M, Hours MM, et al. Rate of pregnancy- related relapse in multiple sclerosis. N Eng J Med 1998;339:283–91
- Dahl J, Myhr KM, Daltveit AK, Gilhus NE. Pregnancy, delivery and birth outcome in different stages of maternal multiple sclerosis. J Neurol 2008;255:623–7
- Chen YH, Lin HI, Lin HC. Does multiple sclerosis increase risk of adverse pregnancy outcomes? A population based study. Mult Scler 2009;15:606–12
- Kelly VM, Nelson LM, Chakravarty EF. Obstetric outcomes in women with multiple sclerosis and epilepsy. Neurology 2009;73:1831–6
- van der Kop ML, Pearce MS, Dahlgren L, et al. Neonatal and delivery outcomes in women with multiple sclerosis. Ann Neurol 2011;70:41–50
- De Las Heras V, De Andrés C, Téllez N, et al. Pregnancy in multiple sclerosis patients treated with immunomodulators prior to or during part of the pregnancy: a descriptive study in the Spanish population. Mult Scler 2007;13:981–4
- Hellwig K, Brune N, Haghikia A, et al. Reproductive counselling, treatment and course of pregnancy in 73 German MS patients. Acta Neurol Scand 2008;118:24–8
- Fragoso YD, Finkelsztejn A, Comini-Frota ER, et al. Pregnancy and multiple sclerosis: the initial results from a Brazilian database. Arq Neuropsiquiatr. 2009;67:657–60
- McDonald WI, Compston A, Edan G, et al. Recommended diagnostic criteria for multiple sclerosis: guidelines from the International Panel on the diagnosis of multiple sclerosis. Ann Neurol 2001;50:121–7
- Polman CH, Reingold SC, Edan G, et al. Diagnostic criteria for multiple sclerosis: 2005 revisions to the “McDonald Criteria”. Ann Neurol 2005;58:840–46
- ICH harmonised tripartite guideline – guideline for good clinical practice: E6(R1). Geneva: International Conference on Harmonisation of Technical Requirements for Registration of Pharmaceuticals for Human Use, June 10, 1996
- Declaration of Helsinki: ethical principles for medical research involving human subjects. Ferney-Voltaire, France: World Medical Association
- Kurtzke JF. Historical and clinical perspectives of the expanded disability status scale. Neuroepidemiology 2008;31:1–9
- Boskovic R, Wide R, Wolpin J, et al. The reproductive effects of beta interferon therapy in pregnancy: a longitudinal cohort. Neurology 2005;65:807–11
- Finkelsztejn A, Brooks JB, Paschoal FM Jr, Fragoso YD. What can we really tell women with multiple sclerosis regarding pregnancy? A systematic review and meta-analysis of the literature. BJOG 2011;118:790–7
- Nelson J.L. Maternal–fetal immunology and autoimmune disease. Is some autoimmune disease auto-alloimmune or allo-autoimmune? Arthrit Rheumat 1996;39:191–4
- Ramagopalan SV, Herrera BM, Valdar W, et al. No effect of birth weight on the risk of multiple sclerosis. A population – based study. Neuroepidemiology 2008;31:181–4